Macrogenics Files DEFA14A Proxy Materials
Ticker: MGNX · Form: DEFA14A · Filed: 2026-04-08T16:02:26-04:00
Sentiment: neutral
Topics: proxy-filing, corporate-governance
Related Tickers: MGNX
TL;DR
MGNX filed proxy docs, likely for shareholder votes. Stay tuned.
AI Summary
Macrogenics Inc. filed a Definitive Additional Materials (DEFA14A) on April 8, 2026, related to proxy solicitations. The filing includes notice pages and a complete submission text file, indicating ongoing corporate communications and shareholder engagement. The company's mailing and business address is 9704 Medical Center Drive, Rockville, MD 20850.
Why It Matters
This filing is a routine but important part of corporate governance, informing shareholders about matters requiring their vote or attention, which can impact company direction.
Risk Assessment
Risk Level: low — This is a standard proxy filing, not indicating immediate financial distress or significant strategic shifts.
Key Players & Entities
- MACROGENICS INC (company) — Filer
- 0001125345 (company) — CIK Number
- 2026-04-08 (date) — Filing Date
- 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 (address) — Mailing and Business Address
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for Additional Definitive Materials and Rule 14(a)(12) material, typically related to proxy solicitations where a company provides supplemental information to shareholders.
When was this specific DEFA14A filing made by Macrogenics Inc.?
This DEFA14A filing was made on April 8, 2026.
What is Macrogenics Inc.'s CIK number?
Macrogenics Inc.'s CIK number is 0001125345.
Where is Macrogenics Inc. located?
Macrogenics Inc.'s mailing and business address is 9704 Medical Center Drive, Rockville, MD 20850.
What type of documents are included in this filing?
This filing includes a DEFA14A document, notice pages (graphic files), and a complete submission text file.
From the Filing
EDGAR Filing Documents for 0001125345-26-000022 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: SEC Accession No. 0001125345-26-000022 Filing Date 2026-04-08 Accepted 2026-04-08 16:02:26 Documents 3 Document Format Files Seq Description Document Type Size 1 DEFA14A defa14a2026.htm DEFA14A 11468 2 NOTICE PAGE 1 mgnx_naax362026page1xpagex1.jpg GRAPHIC 1192193 3 NOTICE PAGE 2 mgnx_naax362026page1xpagex2.jpg GRAPHIC 390739 Complete submission text file 0001125345-26-000022.txt 2190240 Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172 MACROGENICS INC (Filer) CIK : 0001125345 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: DEFA14A | Act: 34 | File No.: 001-36112 | Film No.: 26848095 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)